BR112019003133A2 - agonista de ppargama para o tratamento de distúrbios ósseos - Google Patents

agonista de ppargama para o tratamento de distúrbios ósseos

Info

Publication number
BR112019003133A2
BR112019003133A2 BR112019003133-2A BR112019003133A BR112019003133A2 BR 112019003133 A2 BR112019003133 A2 BR 112019003133A2 BR 112019003133 A BR112019003133 A BR 112019003133A BR 112019003133 A2 BR112019003133 A2 BR 112019003133A2
Authority
BR
Brazil
Prior art keywords
ppargam
agonist
treatment
bone disorders
disorders
Prior art date
Application number
BR112019003133-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Lanfear Dennis
Original Assignee
Intekrin Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intekrin Therapeutics, Inc. filed Critical Intekrin Therapeutics, Inc.
Publication of BR112019003133A2 publication Critical patent/BR112019003133A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
BR112019003133-2A 2016-08-18 2017-08-18 agonista de ppargama para o tratamento de distúrbios ósseos BR112019003133A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662376732P 2016-08-18 2016-08-18
US62/376,732 2016-08-18
PCT/US2017/047584 WO2018035449A1 (en) 2016-08-18 2017-08-18 Pparϒ agonist for treatment of bone disorders

Publications (1)

Publication Number Publication Date
BR112019003133A2 true BR112019003133A2 (pt) 2019-05-21

Family

ID=61197122

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019003133-2A BR112019003133A2 (pt) 2016-08-18 2017-08-18 agonista de ppargama para o tratamento de distúrbios ósseos

Country Status (11)

Country Link
US (1) US20190167660A1 (https=)
EP (1) EP3500269A4 (https=)
JP (2) JP2019524889A (https=)
KR (1) KR20190065252A (https=)
CN (1) CN109843292A (https=)
AU (1) AU2017313842A1 (https=)
BR (1) BR112019003133A2 (https=)
CA (1) CA3033971A1 (https=)
EA (1) EA201990513A1 (https=)
SG (2) SG10202101500WA (https=)
WO (1) WO2018035449A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
JP2020515639A (ja) 2017-04-03 2020-05-28 コヒラス・バイオサイエンシズ・インコーポレイテッド 進行性核上性麻痺の処置のためのＰＰＡＲγアゴニスト

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083427A1 (en) * 2000-04-28 2001-11-08 Sankyo Company, Limited PPARη MODULATORS
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
KR102056756B1 (ko) * 2013-01-30 2019-12-17 인테크린 테라퓨틱스, 아이엔씨. 다발성 경화증의 치료를 위한 PPARγ 작용제
BR112017007426A2 (pt) * 2014-10-10 2018-01-16 Prometic Pharma Smt Limited compostos aromáticos substituídos e composições farmacêuticas para prevenir e tratar osteoporose

Also Published As

Publication number Publication date
EP3500269A4 (en) 2020-04-15
CN109843292A (zh) 2019-06-04
WO2018035449A1 (en) 2018-02-22
SG10202101500WA (en) 2021-03-30
SG11201901328VA (en) 2019-03-28
CA3033971A1 (en) 2018-02-22
JP2022116294A (ja) 2022-08-09
EA201990513A1 (ru) 2019-08-30
AU2017313842A1 (en) 2019-03-07
US20190167660A1 (en) 2019-06-06
KR20190065252A (ko) 2019-06-11
JP2019524889A (ja) 2019-09-05
EP3500269A1 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
JOP20230272A1 (ar) مركبات تثبيط rip1 وطرق لتحضير واستخدامها
MX391850B (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington
MX382033B (es) Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
BR112017006664A2 (pt) terapias de combinação
EA201591612A1 (ru) ПРИМЕНЕНИЕ ПИРАЗОЛПИРИМИДИНОВЫХ ПРОИЗВОДНЫХ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ, СВЯЗАННЫХ С PI3Kδ
EA201691134A1 (ru) Новые ингибиторы глутаминазы
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
MX2016015181A (es) Combinacion de un anticuerpo del receptor 4 de quimiocina anti-cc y un agonista de 4-1 bb para el tratamiento del cancer.
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
MX374452B (es) Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades.
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
PE20180260A1 (es) Metodos y kits para tratar la depresion
MX2017016322A (es) Metodos para tratar tumores de celulas epitelioides.
BR112017006113A2 (pt) combinações sinérgicas de auristatina
MX391040B (es) Formulacion de alta concentracion.
BR112017007704A2 (pt) derivados de pirazolopirimidina como inibidores de nik
BR112017008039A2 (pt) derivados de pirazol como inibidores de nik
BR112017007715A2 (pt) derivados de tienopirimidina como inibidores de nik
BR112018008931A8 (pt) ?compostos para tratamento de distúrbios hipoproliferativos?
MX381544B (es) Composición de células estromales mesenquimatosas para usare en el tratamiento de la sepsis en un sujeto.
BR112015020667A2 (pt) método de preparar inibidores de glucosilceramida sintase
EA201792096A3 (ru) РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА
MX394452B (es) Inhibicion de la actividad de olig2.
BR112018009745A2 (pt) compostos heterocíclicos para o tratamento de doença

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2788 DE 11-06-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.